Triple-negative breast cancer (TNBC), which does not express or express low levels of estrogen receptor, progesterone receptor and HER2/neu, is one of the most invasively malignant human cancers and its incidence increases year by year [1, 2]. This evidence concerns the gene ERBB2 and cancer.